Table 1.
Quality of Care Indicators for Patients at Risk for Chronic Kidney Disease or With Stage 3 or Greater Chronic Kidney Disease as Identified by the Modified Delphi Panel and Proportion of Patients in EMRALD® at Baseline Achieving These Indicators (At-Target) or Identified as High-Risk.
| Criteria for on target | % | Criteria for high risk | % |
|---|---|---|---|
| Indicators for patients at risk for CKD | |||
| Percentage of patients with risk factors for CKD and an eGFR in the past 18 months | 73.6 | Percentage of patients with risk factors for CKD and no eGFR in the past 24 months | 19.8 |
| Percentage of patients with risk factors for CKD and an ACR in the past 18 months | 28.0 | Percentage of patients with risk factors for CKD and no ACR in the past 24 months | 68.4 |
| Percentage of patients with an eGFR <60 mL/min/1.73 m2 and another eGFR in ±6 months | 47.5 | Percentage of patients with an eGFR <60mL/min/1.73 m2 and no eGFR in ±12 months | 32.1 |
| Percentage of patients with an eGFR <60 mL/min/1.73 m2 and an ACR in ±6 months | 16.3 | Percentage of patients with an eGFR <60 mL/min/1.73 m2 and no ACR in ±12 months | 80.9 |
| Percentage of patients with diabetes and albuminuria with a prescription for an ACE inhibitor/ARB | 74.7 | Percentage of patients with diabetes and albuminuria with no prescription for an ACE inhibitor/ARB | 25.3 |
| Indicators for patients with stage 3+ CKD | |||
| Percentage of patients with an ACR in the past 18 months | 34.2 | Percentage of patients with no ACR in the past 24 months | 62.0 |
| Percentage of patients 50 to 80 years with a prescription for a statin | 60.4 | Percentage of patients 50 to 80 years with no prescription for a statin | 39.6 |
| Percentage of patients with a BP recorded in the past 15 months | 91.6 | Percentage of patients with no BP recorded in the past 24 months | 3.9 |
| Percentage of patients with at least one BP measure in the past 15 months meeting BP targets (<140/90 mm Hg for patients <80 years, <150/90 mm Hg for ≥80 years and <130/80 mm Hg for patients with diabetes) | 78.2 | Percentage of patients with at least one BP measure in the past 15 months with BP >160/100 mm Hg | 5.6 |
| Percentage of patients <80 years with an eGFR <30 mL/min/1.73 m2 and who have been seen by a nephrologist | 66.7 | Percentage of patients <80 years with an eGFR <30 mL/min/1.73 m2 and who have not been seen by a nephrologist | 33.3 |
| Percentage of patients with CKD documented in the CPP | 27.1 | Percentage of patients with CKD not documented in the CPP | 72.9 |
| Percentage of patients with ≥1 prescription for NSAIDs | 1.4 | ||
| Percentage of patients with a prescription for an ACE inhibitor and ARB on the same day | 0.7 | ||
Note. EMRALD® = Electronic Medical Record Administrative data Linked Database; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; ACR = albumin to creatinine ratio; ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; BP = blood pressure; CPP = cumulative patient profile; NSAID = nonsteroidal anti-inflammatory drug.